Ep 68: GDF-15 antibody GODFATHER trial
SummaryIn this episode of Melanoma Matters, hosts Sapna Patel and James Larkin discuss the Godfather 15 trial, focusing on the neutralizing GDF 15 antibody and its implications in overcoming PD-1 and ...
24 Jun 202528min
Ep 67: SITC white paper on ICI resistance
SummaryIn this conversation, James Larkin and Sapna Patel discuss the consensus definitions for resistance to immune checkpoint inhibitors, focusing on a recent paper from the Journal of Immunotherapy...
7 Apr 202533min
Ep 66: Ponsegromab for cancer cachexia
SummaryIn this episode of Melanoma Matters, James Larkin and Sapna Patel discuss the recent advancements in understanding and treating cancer cachexia, particularly focusing on the drug ponsegramab. T...
30 Mar 202543min
Ep 65: Opdivo Qvantig (subcutaneous formulation)
SummaryIn this conversation, Sapna Patel and James Larkin discuss the recent approval of Opdivo Qvantiq, a subcutaneous formulation of nivolumab, and its implications for oncology treatment. They expl...
28 Mar 202547min
Ep 64: Guest Clare Turnbull Part 2
In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel pick up with Part 2 of 2 - a deep conversation with Claire Turnbull - about the complexities of cancer screening, overdiagnosis,...
24 Mar 202546min
Ep 63: Guest Clare Turnbull Part 1
SummaryIn this episode of Melanoma Matters, hosts Sapna Patel and James Larkin welcome Clare Turnbull, a clinical geneticist in London, to discuss her journey from studying mathematics to medicine, he...
20 Mar 202528min
Ep 62: Post PD-1 studies
SummaryOn mountain emergencies...Sapna's had them, James denies them...This conversation delves into the treatment options available for patients with advanced melanoma who have progressed after anti ...
18 Mar 202519min
Ep 61: Guest Inge Marie Svane
SummaryIn this episode of Melanoma Matters, host Sapna Patel and James Larkin welcome guest Inge Marie Svane to discuss the evolution and future of cancer immunotherapy, particularly focusing on cellu...
12 Mar 202524min
